Monica Averia-Suboc

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Historically, chemotherapy has remained the most commonly utilized therapy in patients with metastatic cancers. In prostate cancer, chemotherapy has been reserved for patients whose metastatic disease becomes resistant to first line castration or androgen deprivation. While chemotherapy palliates, decreases serum prostate specific antigen and improves(More)
  • 1